viltepso - viltolarsen injection, solution
(Viltolarsen)Ns Pharma, Inc.
Usage: Viltepso treats Duchenne muscular dystrophy (DMD) in patients with a confirmed DMD gene mutation amenable to exon 53 skipping. Approved under accelerated approval based on increased dystrophin production in skeletal muscle.